Your browser doesn't support javascript.
loading
efficacy and side effects of therapy peginterferon alpha-2a [pegasys] combined with ribavirin in chronic hepatitis C patients: an open label clinical trial
Hepatitis Monthly. 2004; 4 (7): 71-74
en Inglés | IMEMR | ID: emr-203599
ABSTRACT
Background and

aims:

peginterferon alpha-2a is a known standard therapy for patients with chronic HCV infection. However, efficacy and safety of this treatment is still unclear in regional settings. This study was designed to clarify efficacy and safety of peg-interferon based therapy in Iranian patients
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Hepat. Monthly Año: 2004

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Hepat. Monthly Año: 2004